Researchers Find Source of Drug-Tolerant Tuberculosis

Jun 12, 2008

University of Pittsburgh-led researchers discovered that the primary bacteria behind tuberculosis can grow on surfaces and that drug-tolerant strains flourish in these bacterial communities, the research team recently reported in “Molecular Microbiology.” The findings suggest a possible reason why human tuberculosis (TB) requires months of intensive antibiotic treatment and indicate a potential cause of the relapses that can nonetheless occur.

The researchers are the first to show that “Mycobacterium tuberculosis” can grow in surface-level bacteria clusters known as biofilms that are common in nature but never before shown for TB bacteria, explained the paper's senior author Graham Hatfull, chair and Eberly Family Professor of Biological Sciences in Pitt's School of Arts and Sciences. Hatfull collaborated and coauthored the paper with Professor William Jacobs Jr. of the Department of Microbiology and Immunology at the Albert Einstein College of Medicine in New York.

Hatfull, Jacobs, and their colleagues found that the biofilm bacteria are physiologically and genetically different from TB bacteria harvested in a lab-the type used in developing antibiotics. These variations result in a population of the bacteria that are “drug-tolerant and harbor persistent cells that survive high concentrations of anti-tuberculosis antibiotics,” the team reports.

People with TB typically undergo six to nine months of treatment with multiple antibiotics and most of the bacteria generally die within the first two weeks. Yet the disease can recur, presumably because of drug-tolerant bacteria that have escaped the antibiotic. The source and location of these persistent cells are unknown, but Hatfull and Jacobs' research reveals a possible biofilm origin, Jacobs said.

“The nature of persisting “M. tuberculosis” cells has been an enigma for the entire field,” Jacobs said. “Clearly “M. tuberculosis” cells in biofilms represent at least one class of persistent cells, and we are testing their biological relevance.”

It is not yet known whether the biofilm actually factors into human TB infections, Hatfull said. He added that the only similar research regarding biofilm in living creatures showed the presence of biofilm-like or biofilm-related bacteria in guinea pigs.

“While our data does not show conclusively that biofilm formation in people gives rise to a drug-tolerant population, the fact that biofilms do so in the lab makes this an interesting and testable hypothesis,” Hatfull said.

Other collaborators on the project include: Yann Guerardel and associate Xavier Trivelli of the Universite des Sciences et Technologies de Lille in France; Laurent Kremer and associate Anuradha Alahari of France's University of Montpellier; Pitt postdoctoral researcher Anil Ojha; and Jacobs' research associates Anthony Baughn, Dhinakaran Sambandan, and Tsungda Hsu.

The full paper can be read on the “Molecular Microbiology” Web site at www.blackwell-synergy.com/doi/… 65-2958.2008.06274.x

Source: University of Pittsburgh

Explore further: The impact of bacteria in our guts

add to favorites email to friend print save as pdf

Related Stories

Exploring Mars in low Earth orbit

Jul 31, 2014

In their quest to understand life's potential beyond Earth, astrobiologists study how organisms might survive in numerous environments, from the surface of Mars to the ice-covered oceans of Jupiter's moon, ...

Biomarkers of the deep

Jul 25, 2014

Tucked away in the southwest corner of Spain is a unique geological site that has fascinated astrobiologists for decades. The Iberian Pyrite Belt (IPB) in Spain's Río Tinto area is the largest known deposit ...

Recommended for you

The impact of bacteria in our guts

Aug 22, 2014

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

Aug 22, 2014

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

Aug 22, 2014

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments : 0